Ono Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was $6,193 Mil.
During the past 12 months, Ono Pharmaceutical Co's average Total Assets Growth Rate was 15.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 5.50% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 13 years, Ono Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 12.70%. The lowest was -7.80%. And the median was 5.75%.
Ono Pharmaceutical Co Total Assets Historical Data
The historical data trend for Ono Pharmaceutical Co's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Ono Pharmaceutical Co's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (OTCPK:OPHLY) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Ono Pharmaceutical Co's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Ono Pharmaceutical Co Total Assets Related Terms
Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description
Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.
Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OPHLY has been successfully added to your 